#ThinkSabio Latest News

CareDx Announces Preliminary Fourth Quarter and Full Year 2024 Results

Preliminary Q4 2024 Financial Highlights:
Revenue: $85M–$86M (+30% YoY).
Testing Services Revenue: $62.5M–$63.5M (+35% YoY).
Testing Volume: 45,500 tests (+14% YoY).

Preliminary Full Year 2024 Financial Highlights:
Revenue: $332M–$333M. , GAAP Loss: $58M–$60M.
Adjusted EBITDA: $25M–$26M gain.